Medicine guide

Pantoprazole Kalceks

On the Bulgarian pack: Пантопразол Калцекс 40 mg прах за инжекционен разтвор

40 mg · powder for solution for injection

  • Prescription only
  • Digestion, stomach, diabetes and nutrition
Active substance
Pantoprazole
Made by
AS Kalceks

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupDigestion, stomach, diabetes and nutritionA02BC02

Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet

How it works

This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (pantoprazole sodium). It describes the substance, not this Bulgarian product — its uses and doses can differ.

Pantoprazole is a PPI that suppresses the final step in gastric acid production by covalently binding to the (H +, K + )-ATPase enzyme system at the secretory surface of the gastric parietal cell.

This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus.

How the body breaks it down

Pantoprazole is extensively metabolized in the liver through the cytochrome P450 (CYP) system.

How it leaves the body

After a single oral or intravenous dose of 14 C-labeled pantoprazole to healthy, normal metabolizer subjects, approximately 71% of the dose was excreted in the urine, with 18% excreted in the feces through biliary excretion.

With food

Administration of pantoprazole sodium delayed-release tablets with food may delay its absorption up to 2 hours or longer; however, the C max and the extent of pantoprazole absorption (AUC) are not altered.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-05

Safety of the active substance

This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (pantoprazole sodium). It describes the substance, not this Bulgarian product — its uses and doses can differ.

Must not be used by
  • Pantoprazole sodium is contraindicated in patients with known hypersensitivity to any component of the formulation or any substituted benzimidazole.
  • Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see Warnings and Precautions (5.2), Adverse Reactions (6) ].
  • Proton pump inhibitors (PPIs), including pantoprazole sodium, are contraindicated in patients receiving rilpivirine-containing products [see Drug Interactions (7) ].
  • Patients with known hypersensitivity to any component of the formulation or to substituted benzimidazoles ( 4 ) Patients receiving rilpivirine-containing products ( 4, 7 )
Most common side effects

The most frequently occurring adverse reactions are listed in Table 3.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byAS Kalceks · Latvia
Active substancePantoprazole
Used inDigestion, stomach, diabetes and nutrition
Strength40 mg
Formpowder for solution for injection
Pack sizes1 · 5 · 10 · 50
ClassificationA02BC02 · Digestion, stomach, diabetes and nutrition
Name in the registerПантопразол Калцекс 40 mg прах за инжекционен разтвор
Reg. no.20230181

Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician

Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.